Inflammation and reactivation of latent herpesviruses in older adults

Brain, Behavior, and Immunity

Volumn 26, Issue 5, 2012, Pages 739-746

  Bennett, Jeanette M ^a,b   Glaser, Ronald ^a,b   Malarkey, William B ^b   Beversdorf, David Q ^c,d   Peng, Juan ^a   Kiecolt Glaser, Janice K ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF MISSOURI   (United States)

^d University of Missouri   (United States)

Author keywords

Aging; C reactive protein (CRP); Cytomegalovirus (CMV); Epstein Barr virus (EBV); Immunosenescence; Interleukin 6 (IL 6); Latent reactivation

Indexed keywords

C REACTIVE PROTEIN; CYTOMEGALOVIRUS ANTIBODY; EPSTEIN BARR VIRUS ANTIBODY; INTERLEUKIN 6; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ADULT; AGED; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; FEMALE; HUMAN; INFLAMMATION; LATENT VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEROCONVERSION; VIRUS REACTIVATION;

AGED; ANTIBODIES, VIRAL; BODY MASS INDEX; C-REACTIVE PROTEIN; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DEPRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRIDAE; HERPESVIRUS 4, HUMAN; HUMANS; INFLAMMATION; INTERLEUKIN-6; LEAST-SQUARES ANALYSIS; MALE; MIDDLE AGED; SLEEP; VIRUS ACTIVATION; VIRUS LATENCY;

EID: 84861961314     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2011.11.007     Document Type: Article

References (70)

1. Aiken L.S., West S.G. Interactions between continuous predictors in multiple regression. Multiple Regression: Testing and Interpreting Interactions 1991, 9-27. Sage, Newbury Park.
2. Almeida G.D., Porada C., St Jeor S., Ascensao J. Human cytomegalovirus alters interleukin-6 production by endothelial cells. Blood 1994, 83:370-376.
3. Amar S., Gokce N., Morgan S., Loukideli M., Van Dyke T.E., Vita J.A. Periodontal disease is associated with brachial artery endothelial dysfunction and systemic inflammation. Arterioscler. Thromb. Vasc. Biol. 2003, 23:1245-1249.
4. Ariza M.E., Glaser R., Kaumaya P.T., Jones C., Williams M.V. The EBV-encoded dUTPase activates NF-kappa B through the TLR2 and MyD88-dependent signaling pathway. J. Immunol. 2009, 182:851-859.
5. Aronson D., Avizohar O., Levy Y., Bartha P., Jacob G., Markiewicz W. Factor analysis of risk variables associated with low-grade inflammation. Atherosclerosis 2008, 200:206-212.
6. Aviv A. Telomeres and human aging: facts and fibs. Sci. Aging Knowledge Environ. 2004, 51:pe43.
7. Backhaus J., Junghanns K., Broocks A., Riemann D., Hohagen F. Test-retest reliability and validity of the Pittsburgh Sleep Quality Index in primary insomnia. J. Psychosom. Res. 2002, 53:737-740.
8. Ballou S.P., Lozanski G.B., Hodder S., Rzewnicki D.L., Mion L.C., Sipe J.D., Ford A.B., Kushner I. Quantitative and qualitative alterations of acute-phase proteins in healthy elderly persons. Age Ageing 1996, 25:224-230.
9. Basco M.R., Krebaum S.R., Rush A.J. Outcome measures of depression. Measuring Patient Changes in Mood, Anxiety, and Personality Disorders 1997, 207-245. American Psychological Association, Washington, DC. H.H. Strupp, L.M. Horowitz, M.J. Lambert (Eds.).
10. Bauer J., Hohagen F., Ebert T., Timmer J., Ganter U., Krieger S., Lis S., Postler E., Voderholzer U., Berger M. Interleukin-6 serum levels in healthy persons correspond to the sleep-wake cycle. Clin. Invest. 1994, 72:315.
11. Blackburn E.H. Switching and signaling at the telomere. Cell 2001, 106:661-673.
12. Blankenberg S., Rupprecht H.J., Bickel C., Espinola-Klein C., Rippin G., Hafner G., Ossendorf M., Steinhagen K., Meyer J. Cytomegalovirus infection with interleukin-6 response predicts cardiac mortality in patients with coronary artery disease. Circulation 2001, 103:2915-2921.
13. Bremmer M.A., Beekman A.T., Deeg D.J., Penninx B.W., Dik M.G., Hack C.E., Hoogendijk W.J. Inflammatory markers in late-life depression: results from a population-based study. J. Affect. Disord. 2008, 106:249-255.
14. Bruunsgaard H., Pedersen B.K. Age-related inflammatory cytokines and disease. Immunol. Allergy Clin. North Am. 2003, 23:15-39.
15. Burns L.J., Pooley J.C., Walsh D.J., Vercellotti G.M., Weber M.L., Kovacs A. Intercellular adhesion molecule-1 expression in endothelial cells is activated by cytomegalovirus immediate early proteins1. Transplantation 1999, 67:137-144.
16. Bush T.L., Miller S.R., Golden A.L., Halle W.E. Self-reports and medical report agreement of selected medical conditions in the elderly. Am. J. Public Health 1989, 79:1554-1556.
17. Buysse D.J., Reynolds C.F., Monk T.H., Berman S.R., Kupfer D.J. Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989, 28:193-213.
18. Cannon J. Cytokines in aging and muscle homeostasis. J. Gerontol. Ser. A 1995, 50:120-123.
19. Cook N.R., Buring J.E., Ridker P.M. The effect of including C-reactive protein in cardiovascular risk prediction models for women. Ann. Intern. Med. 2006, 145:21-29.
20. Danese A., Moffitt T.E., Pariante C.M., Ambler A., Poulton R., Caspi A. Elevated inflammation levels in depressed adults with a history of childhood maltreatment. Arch. Gen. Psychiatry 2008, 65:409-415.
21. De Martinis M., Franceschi C., Monti D., Ginaldi L. Inflammation markers predicting frailty and mortality in the elderly. Exp. Mol. Pathol. 2006, 80:219-227.
22. Epel E.S. Telomeres in a life-span perspective: a new " psychobiomarker" ?. Curr. Dir. Psychol. Sci. 2009, 18:6-10.
23. Ershler W., Keller E. Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annu. Rev. Med. 2000, 51:245-270.
24. Ferrucci L., Cavazzini C., Corsi A., Bartali B., Russo C.R., Lauretani F., Corsi A.M., Bandinelli S., Guralnik J.M. Biomarkers of frailty in older persons. J. Endocrinol. Invest. 2002, 25:10-15.
25. Ferrucci L., Corsi A., Lauretani F., Bandinelli S., Bartali B., Taub D.D., Guralnik J.M., Longo D.L. The origins of age-related proinflammatory state. Blood 2005, 105:2294-2299.
26. Fillenbaum G.G., Smyer M.A. The development, validity, and reliability of the OARS multidimensional functional assessment questionnaire. J. Gerontol. 1981, 36:428-434.
27. Franceschi C., Bonafe M., Valensin S. Human immunosenescence: the prevailing of innate immunity, the failing of clonotypic immunity, and the filling of immunological space. Vaccine 2000, 18:1717-1720.
28. Glaser R., Jones J.F. Herpesvirus Infections 1994, M. Dekker, New York.
29. Glaser R., Kiecolt-Glaser J.K. Stress-associated immune modulation and its implications for reactivation of latent herpesviruses. Herpesvirus Infections 1994, 245-270. M. Dekker, New York. R. Glaser, J. Jones (Eds.).
30. Glaser R., KiecoltGlaser J.K. Chronic stress modulates the virus-specific immune response to latent herpes simplex virus type 1. Ann. Behav. Med. 1997, 19:78-82.
31. Glaser R., Litsky M.L., Padgett D.A., Baiocchi R.A., Yang E.V., Chen M., Yeh P.E., Green-Church K.B., Caligiuri M.A., Williams M.V. EBV-encoded dUTPase induces immune dysregulation: Implications for the pathophysiology of EBV-associated disease. Virology 2006, 346:205-218.
32. Hamer M., Chida Y. Associations of very high C-reactive protein concentration with psychosocial and cardiovascular risk factors in an ageing population. Atherosclerosis 2009, 206:599-603.
33. Hamer M., Chida Y., Stamatakis E. Association of very highly elevated C-reactive protein concentration with cardiovascular events and all-cause mortality. Clin. Chem. 2010, 56:132-135.
34. Haringsma R., Engels G.I., Beekman A.T.F., Spinhoven P. The criterion validity of the Center for Epidemiological Studies Depression Scale (CES-D) in a sample of self-referred elders with depressive symptomatology. Int. J. Geriatr. Psychiatry 2004, 19:558-563.
35. Iwasaki A., Medzhitov R. Regulation of adaptive immunity by the innate immune system. Science 2010, 327:291-295.
36. Jaye D.L., Waites K.B. Clinical applications of C-reactive protein in pediatrics. Pediatr. Infect. Dis. J. 1997, 16:735-747.
37. Kehoe R., Wu S.Y., Leske M.C., Chylack L.T. Comparing self-reported and physician reported medical history. Am. J. Epidemiol. 1994, 139:813-818.
38. Kiecolt-Glaser J., Dura J., Speicher C., Trask O., Glaser R. Spousal caregivers of dementia victims: longitudinal changes in immunity and health. Psychosom. Med. 1991, 53:345-362.
39. Kiecolt-Glaser J.K., Glaser R. Psychological stress, telomeres, and telomerase. Brain Behav. Immun. 2010, 24:529-530.
40. Maes M., Meltzer H.Y., Bosmans E., Bergmans R., Vandoolaeghe E., Ranjan R., Desnyder R. Increased plasma-concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. J. Affect Disord. 1995, 34:301-309.
41. Mathur N., Pedersen B.K. Exercise as a mean to control low-grade systemic inflammation. Mediators Inflamm. 2008, 10.1155/2008/109502.
42. Meier-Ewert H.K., Ridker P.M., Rifai N., Price N., Dinges D.F., Mullington J.M. Absence of diurnal variation of C-reactive protein concentrations in healthy human subjects. Clin. Chem. 2001, 47:426-430.
43. Miller G.E., Freedland K.E., Duntley S., Carney R.M. Relation of depressive symptoms to C-reactive protein and pathogen burden (cytomegalovirus, herpes simplex virus, Epstein-Barr virus) in patients with earlier acute coronary syndromes. Am. J. Cardiol. 2005, 95:317-321.
44. Mohamed-Ali V., Goodrick S., Rawesh A., Katz D.R., Miles J.M., Yudkin J.S., Klein S., Coppack S.W. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J. Clin. Endocrinol. Metab. 1997, 82:4196-4200.
45. Moldofsky H., Lue F.A., Eisen J., Keystone E., Gorczynski R.M. The relationship of interleukin-1 and immune functions to sleep in humans. Psychosom. Med. 1986, 48:309-318.
46. Nazmi A., Diez-Roux A.V., Jenny N.S., Tsai M.Y., Szklo M., Aiello A.E. The influence of persistent pathogens on circulating levels of inflammatory markers: a cross-sectional analysis from the Multi-Ethnic Study of Atherosclerosis. BMC Public Health 2010, 10:706.
47. Pawelec G., Derhovanessian E., Larbi A., Strindhall J., Wikby A. Cytomegalovirus and human immunosenescence. Rev. Med. Virol. 2009, 19:47-56.
48. Pearson T.A., Mensah G.A., Alexander R.W., Anderson J.L., Cannon R.O., Criqui M., Fadl Y.Y., Fortmann S.P., Hong Y., Myers G.L., Rifai N., Smith S.C., Taubert K., Tracy R.P., Vinicor F. Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003, 107:499-511.
49. Pedersen B.K., Febbraio M.A. Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physiol. Rev. 2008, 88:1379-1406.
50. Pepys M.B., Hirschfield G.M. C-reactive protein: a critical update. J. Clin. Invest. 2003, 111:1805-1812.
51. Radloff L.S. The CES-D scale: a self-report depression scale for research in the general population. Appl. Psychol. Meas. 1977, 1:385-401.
52. Ridker P.M. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003, 107:363-369.
53. Ridker P.M., Cook N. Clinical usefulness of very high and very low levels of C-reactive protein across the full range of Framingham risk scores. Circulation 2004, 109:1955-1959.
54. Roberts E.T., Haan M.N., Dowd J.B., Aiello A.E. Cytomegalovirus antibody levels, inflammation, and mortality among elderly Latinos over 9 years of follow-up. Am. J. Epidemiol. 2010, 172:363-371.
55. Roberts R., Vernon S. The Center for Epidemiologic Studies Depression Scale: its use in a community sample. Am. J. Psychiatry 1983, 140:41-46.
56. Schmaltz H.N., Fried L.P., Xue Q.L., Walston J., Leng S.X., Semba R.D. Chronic cytomegalovirus infection and inflammation are associated with prevalent frailty in community-dwelling older women. J. Am. Geriatr. Soc. 2005, 53:747-754.
57. Shurin G.V., Yurkovetsky Z.R., Chatta G.S., Tourkova I.L., Shurin M.R., Lokshin A.E. Dynamic alteration of soluble serum biomarkers in healthy aging. Cytokine 2007, 39:123-129.
58. Simanek, A.M., Dowd, J.B., Pawelec, G., Melzer, D., Dutta, A., Aiello, A.E., 2011. Seropositivity to cytomegalovirus, inflammation, all-cause and cardiovascular disease-related mortality in the United States. PLoS ONE. 6.
59. Staras S.A., Dollard S.C., Radford K.W., Flanders W.D., Pass R.F., Cannon M.J. Seroprevalence of cytomegalovirus infection in the United States, 1988-1994. Clin. Infect. Dis. 2006, 43:1143-1151.
60. Stowe R.P., Kozlova E.V., Yetman D.L., Walling D.M., Goodwin J.S., Glaser R. Chronic herpesvirus reactivation occurs in aging. Exp. Gerontol. 2007, 42:563-570.
61. Tonetti M.S., D'Aiuto F., Nibali L., Donald A., Storry C., Parkar M., Suvan J., Hingorani A.D., Vallance P., Deanfield J. Treatment of periodontitis and endothelial function. N. Engl. J. Med. 2007, 356:911-920.
62. Trzonkowski P., Mysliwska J., Szmit E., Wieckiewicz J., Lukaszuk K., Brydak L.B., Machala M., Mysliwski A. Association between cytomegalovirus infection, enhanced proinflammatory response and low level of anti-hemagglutinins during the anti-influenza vaccination - an impact of immunosenescence. Vaccine 2003, 21:3826-3836.
63. Visser M., Bouter L.M., McQuillan G.M., Wener M.H., Harris T.B. Elevated C-reactive protein levels in overweight and obese adults. JAMA 1999, 282:2131-2135.
64. Waage A., Brandtzaeg P., Halstensen A., Kierulf P., Espevik T. The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome. J. Exp. Med. 1989, 169:333-338.
65. Waldman W.J., Williams M.V., Lemeshow S., Binkley P., Guttridge D., Kiecolt-Glaser J.K., Knight D.A., Ladner K.J., Glaser R. Epstein-Barr virus-encoded dUTPase enhances proinflammatory cytokine production by macrophages in contact with endothelial cells: evidence for depression-induced atherosclerotic risk. Brain Behav. Immun. 2008, 22:215-223.
66. Walston J., McBurnie M.A., Newman A., Tracy R.P., Kop W.J., Hirsch C.H., Gottdiener J., Fried L.P. Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study. Arch. Intern. Med. 2002, 162:2333-2341.
67. Wang G.C., Kao W.H., Murakami P., Xue Q.L., Chiou R.B., Detrick B., McDyer J.F., Semba R.D., Casolaro V., Walston J.D., Fried L.P. Cytomegalovirus infection and the risk of mortality and frailty in older women: a prospective observational cohort study. Am. J. Epidemiol. 2010, 171:1144-1152.
68. WHO, 2008. World Health Organization: immunization, vaccines and biologicals - Epstein-Barr virus.
69. Zhu J., Quyyumi A.A., Norman J.E., Csako G., Waclawiw M.A., Shearer G.M., Epstein S.E. Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels. Am. J. Cardiol. 2000, 85:140-146.
70. Zhu J.H., Quyyumi A.A., Norman J.E., Csako G., Epstein S.E. Cytomegalovirus in the pathogenesis of atherosclerosis - the role of inflammation as reflected by elevated C-reactive protein levels. J. Am. Coll. Cardiol. 1999, 34:1738-1743.